MedPath

The Netherlands Chlamydia Cohort Study

Recruiting
Conditions
Genital Chlamydia trachomatis infectionPelvic Inflammatory Disease (PID)Ectopic pregnancy(Tubal) infertilityProlonged time to pregnancyGenitale Chlamydia trachomatis infectiePIDEctopische zwangerschapTubaire infertiliteitVerlengde duur tot zwangerschap
Registration Number
NL-OMON23749
Lead Sponsor
ational Institute for Public Health and the Environment (RIVM)VUmc
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
14685
Inclusion Criteria

Being a women;

- Participated in at least one round of the Chlamydia Screening Implementation between 2008 and 2011;

Exclusion Criteria

- Not living in the Netherlands anymore;

- No traceable address information.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The main outcomes of the study are Pelvic Inflammatory Disease (PID), ectopic pregnancy, tubal infertility and time to pregnancy. The primary study parameter is the presence<br>of a previous Chlamydia trachomatis infection.
Secondary Outcome Measures
NameTimeMethod
The secondary study parameters include candidate host genetic biomarkers (SNPs) and behavioural, demographic, and pathogen factors<br>possibly associated with the development of Chlamydia trachomatis related complications.
© Copyright 2025. All Rights Reserved by MedPath